OUR STORY

Translating scientific innovation into better healthcare technology.

From university research to a new generation of implantable sensing solutions.

WHO WE ARE

FORESEE MedTech.

FORESEE MedTech is a medical technology spin-off of Universitat Pompeu Fabra (UPF), based in Barcelona, Spain.

We are developing an innovative intravascular microsensing platform designed to provide more comprehensive physiological monitoring for patients living with heart failure.

Our mission is to combine scientific innovation, advanced engineering, and clinical needs to develop reliable and scalable implantable monitoring technology.

OUR SCIENTIFIC ORIGINS

Built on scientific excellence.

FORESEE builds on research at Universitat Pompeu Fabra in bioelectrical phenomena, wireless power transfer, and communication through volume conduction.

Scientific work led by Prof. Antoni Ivorra established the foundations of the technology, which subsequently progressed through European Research Council projects and translational research activities.

FORESEE was established to advance this scientific foundation towards a new generation of implantable medical technologies.

2017

ERC CONSOLIDATOR GRANT

The eAXON project established scientific foundations for volume-conduction-based implantable technologies.

2020

ERC PROOF OF CONCEPT

Explored the potential of eAXON technology for implantable sensing applications.

2023

EIC TRANSITION

€2.5 million in competitive European funding supporting technology maturation and validation.

2026

SPIN-OFF CREATION

Establishment of FORESEE MedTech as a Universitat Pompeu Fabra (UPF) spin-off to translate the technology into a multiparametric implantable medical platform.

Our mission: making advanced physiological monitoring more accessible.

MEET THE TEAM →

OUR SUPPORT

Previous funding

The FORESEE project builds on the grounds of four innovation actions: the UPF INNOValora 2019 project (30 k€) and the European Research Council (ERC) Proof of Concept project Senso-eAXON (150 k€) granted to Prof. Antoni Ivorra (Grant agreement No. 963955), the CaixaResearch Validate project IntraSenso-eAXON (70 k€) granted to Dr. Laura Becerra-Fajardo (Project Number: CI21-00191) and the EIC Transition project FORESEE (2.5 M€, grant agreement No. 101136633).

OUR NETWORK

Collaborators

We thank our patient and clinician association collaborators for their insights, which guide us in designing a solution that truly meet the needs of people living with heart failure.

OUR journey

Acceleration programs

We have participated in national and international accelerator programs, which have provided valuable mentorship, networking opportunities, and the resources to accelerate our growth and innovation.